medical-marijuana-stethoscope-michael-king-cannabis-palm-springs

New Mexico: Health Secretary Balks At Medical Cannabis Expansion

Santa Fe: Health Secretary Lynn Gallagher has agreed to proposed changes in the state’s medical cannabis law that would permit patients with obstructive sleep apnea to access marijuana; but she rejected calls to expand access to patients with other debilitating conditions, including Tourette’s syndrome (TS) and opioid dependency.

“I cannot say with any degree of confidence that the use of cannabis for the treatment of opioid dependence and its symptoms would be either safe or effective,” Secretary Gallagher opined in a signed decision. She also rejected recommendations to permit the use of cannabis for the treatment of eczema, muscular dystrophy, psoriasis, or Tourette’s syndrome.

A number of case reports and clinical trials report that THC can mitigate symptoms of TS. Cannabis use has also been associated with improved outcomes in opioid-dependent subjects undergoing outpatient treatment. Among chronic pain patients enrolled in medical cannabis programs, the use of opioids typically is reduced or eliminated over time.

Original Press Release

 

About Michael King Cannabis

Michael King is an experienced cannabis professional out of Palm Springs with a background in finance, private equity, real estate and consulting. He is currently a principal in one of the leading Cannabis consulting firms in the country.

Read More
chai-dispensary-santa-cruz-capitola-michael-king-cannabis

Canadian Cannabis Company Captor Capital Buys San Jose Dispensary for $6 Million

Leading Santa Cruz Dispensary Acquired by Captor Capital

Adding Chai Cannabis continues to increase presence in California retail cannabis market September 18, 2018

TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) — Captor Capital Corp. (“Captor” or the “Company”) (CSE: CPTR; FRANKFURT: NMV;USOTC:NWURF) announced today it has completed its previously announced acquisition of a dispensary in Santa Cruz, California, Chai Cannabis Inc. (“Chai”). Chai also possesses a license permitting cannabis delivery within the greater Santa Cruz area. Adding this dispensary, one of the most popular in the area (unaudited revenues of USD$8.4 in 2017), is expected to materially increase total revenues from Captor’s retail cannabis investments.

Chai was acquired for a total consideration of USD$6,015,000, of which USD$4,390,950 was payable in cash closing, USD$721,800 of which was in the form of a promissory note and USD$902,250 was paid in shares of Captor. The portion of the consideration paid in Captor shares was converted into approximately C$1,187,722 and 7,662,722 Captor Shares were issued at a deemed issue price of $0.155.

Dispensary renovations are set to begin shortly that will triple Chai’s sales floor space. The newly renovated space will allow Chai to carry a much wider range of flowers, edibles, extracts, and other cannabis products. Chai will remain open during the renovations and it is not expected to impact the dispensary’s operations. Manager of Chai, Josh Lechner, has been successfully operating the dispensary since it opened in 2014 and will continue on in this role.

The Chai brand adds a unique retail experience to the consumer which complements Captor’s premium branded MedMen (MMEN.CN), stores in West Hollywood and Santa Ana. The acquisition of Chai continues Captor’s business plan to aggressively invest in California’s retail; cannabis industry. Captor’s investment in this profitable dispensary represents a fantastic growth opportunity. We believe the Santa Cruz area with more than 4 million tourists visiting each year will become a growing retail cannabis market.”

About Captor Capital

Captor Capital Corp. is a Canadian firm focused on the cannabis sector listed on the Canadian Securities Exchange, the OTC, and the Frankfurt Stock Exchange. A vertically integrated cannabis company, Captor provides recreational and medical marijuana based products to consumers via its leading brands and dispensary locations. Listed on the Canadian Securities Exchange, the OTCUSA, and the Frankfurt Stock Exchange, Captor owns and operates advanced growing facilities which produce consistent high-quality contaminant free marijuana for its customers, as well as other high demand cannabis-based goods for consumption. 
The company follows a strategy of acquiring cash flowing established companies and organizations with growth potential that require capital to scale. Captor currently has a number of revenue generating cannabis investments including two wholly owned branded MedMen dispensaries – the world famous West Hollywood location and the showpiece Orange County dispensary in Santa Ana. Captor Capital is currently looking at additional revenue generating investments in the cannabis space and will be updating the market in due course.

 

Original Press Release


About Michael King

Michael King is an experienced professional with a background in finance, private equity, real estate and consulting. He is currently a principal in one of the leading Cannabis consulting firms in the country based out of Palm Springs — Kings Garden Inc.

Read More
study-suggests-cbd-may-have-antipsychotic-effect-high-risk-individuals-featured Michael King Cannabis Palm Springs

Study Suggests CBD May Have Antipsychotic Effect in Individuals

The psychiatric research journal JAMA Psychiatry has just published a new study suggesting CBD could have antipsychotic effects in individuals at clinical high risk of psychosis. The study builds off compelling prior research demonstrating CBD’s therapeutic effects. Titled “Effect of Cannabidiol on Medial Temporal, Mid-brain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis,” the randomized clinical trial sheds important light not just on whether or not CBD has calming cognitive effects, but also how it produces them.

Psychiatrists Investigate the Underlying Causes for CBD’s Therapeutic Effects

What are the neurocognitive mechanisms that underlie the putative therapeutic effects of cannabidiol in psychosis? In other words, does CBD really help treat psychosis? And if so, how? Such are the questions motivating a new study published in JAMA Psychiatry.

Researchers began with the premise that cannabidiol (CBD) has antipsychotic effects in humans. Exactly how it has that effect on the brain isn’t fully understood. Psychiatrists study the chemical reactions that lead to or stem from atypical mental states. For this study, researchers wanted to try to isolate the specific chemical alterations that give CBD its therapeutic and potentially antipsychotic effects.

To do so, the study examined the effects of CBD in 33 individuals at clinical high risk (CHR) of psychosis. Previous studies have identified the regions of the brain that become perturbed in individuals with psychosis and at CHR. So the JAMA study had a hypothesis: maybe CBD attenuates, or lessens, those disturbances in the parts of the brain associated with psychosis.

Study’s Findings Confirm CBD’s Influence on Brain Regions Implicated in Psychosis

The study’s 33 CHR participants were part of a double-blind randomized clinical trial with 19 healthy control individuals. Some participants received a single, 600 mg oral dose of cannabidiol; others, no CBD or a placebo. Researchers examined how the CBD affected the striatum, medial temporal cortex, and midbrain—the target brain regions.

The investigation revealed that all three brain regions experienced modulated activation as a result of the CBD. Using an MRI while participants performed a verbal learning task, researchers measured brain activation alongside healthy control individuals who took no CBD, and high-risk patients who received a placebo. What they found was that CHR patients who took CBD had activation levels about in the middle between healthy individuals with no disturbances and CHR patients who took no CBD.

In short, CBD did have the attenuating effects researchers had hypothesized. The oral dose of cannabidiol helped normalize dysfunction in all three brain regions. And that means the study may have identified one of the mechanisms responsible for CBD’s therapeutic benefits.

While the study’s findings have implications for psychiatric medicine and treating individuals at high risk for psychosis, it has wider importance for anyone interested in the effects of cannabis on mental health.

There are studies that have drawn links between regular and frequent cannabis use and the development of psychosis. Others have linked psychosis with changes to the endocannabinoid system, whether cannabinoid-stimulated or not. At the same time, research shows CBD, a non-psychoactive cannabinoid, has an almost opposite neural and behavioral effect to THC. With this latest study, scientists now know more about why that is.

 

article via High Times

 


About Michael King

Michael King is an experienced professional with a background in finance, private equity, real estate and consulting. He is currently a principal in one of the leading Cannabis consulting firms in the country based out of Palm Springs — Kings Garden Inc.

Read More
Community outreach helping cannabis companies - Michael King Cannabis Palm Springs

Community outreach helping cannabis companies gain edge on rivals, attract customers

Article Published by: mjbizdaily.com

Cannabis companies nationwide are finding they can reap generous rewards from giving to their local communities.

Being a good corporate citizen can make it easier for marijuana businesses to work with regulators and local officials, stand out from competitors and attract new customers and high-quality employees, according to industry executives and experts on corporate giving.

There are a variety of ways cannabis companies can give back to their communities, ranging from providing volunteer time for events and projects to collecting food donations.

And with U.S. cannabis retail sales estimated to reach between $8 billion and $10 billion in 2018, many MJ businesses have room in their budgets to cut checks to cause-driven organizations.

“Giving back has always been a part of my life, but part of my mission is also breaking stereotypes about people who use cannabis as not being contributing members to society,” said Annette Atkinson, owner of HWY420, a Washington state marijuana retailer that has been recognized for its charitable giving.

“If I can increase the population that believes marijuana is an OK alternative to alcohol and opioids through showing that people who use marijuana are not horrible people, then on the business side, I think that will help me.”

In some states, giving back isn’t just good business; it’s required to even open for business.

In 2016, Denver started requiring applicants for retail marijuana licenses – and those seeking to renew their permits – to submit “community engagement” plans.

The idea was to “create positive impacts in the neighborhoods where the licensed premises are located.”

Some options for companies include:

  • Neighborhood Beautification.
  • Increasing access to healthy food.
  • Homelessness assistance.
  • Improving connectivity and transportation.

Municipalities such as Oakland, California, and Thornton, Colorado, also have adopted requirements aimed at ensuring the marijuana industry creates social benefits.

Similarly, Pennsylvania, Ohio and other states rolling out new marijuana markets are introducing merit-based application programs as well, making community outreach and engagement increasingly important in the industry, said Courtney Mathis, president, and co-founder of KindColorado.

Denver-based KindColorado helps cannabis companies in the state strategize how to connect with neighborhood groups and nonprofits.

Among other activities, KindColorado has organized opportunities for marijuana company employees to pull weeds alongside refugee farmers, serve food for women struggling with poverty and fund senior-focused food banks.

“Cannabis companies are really becoming a part of their communities, and they feel really lucky about that,” said Kelly Perez, co-founder, and CEO of KindColorado.

“It isn’t about hitting licensing requirements. It’s about getting to serve a community where you don’t have to be in the shadows anymore: Coming out, standing tall and using your privilege and opportunity to be an asset.”


About Michael King

Michael King is an experienced professional with a background in finance, private equity, real estate and consulting. He is currently a principal in one of the leading Cannabis consulting firms in the country based out of Palm Springs — Kings Garden Inc.

Read More